NEKTAR THERAPEUTICS NKTR Income Statement

Nektar therapeutics (NKTR)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Revenue:
Total revenue
136,968	114,617	120,581	119,125	1,183,527	1,193,323	1,248,963	1,374,129	321,001	307,711	249,695	133,103	131,282	165,436	167,356	190,972	180,865	230,784	210,966	283,885	289,737	200,707	212,301	140,339	145,688	148,921	138,921	96,424	86,246	81,191	75,827	84,483	78,130	71,480	101,012	111,869	137,101	159,039	0	0	0
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	46,011	-	55,637	48,179	46,280	40,155	0	0	0	-	-	-	-	-	-	-	-	35,399	0	0	0	-	-	-	-	-	-	-	-
Royalty revenue
-	-	-	-	-	-	-	-	-	-	-	-	22,698	-	15,060	9,674	6,903	2,967	0	0	0	-	-	-	-	-	-	-	-	4,874	0	0	0	-	-	-	-	-	-	-	-
Product sales and royalty revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	0	0	0	-	0	0	0
Non-cash royalty revenue related to sale of future royalties
-	-	-	-	-	-	-	-	-	-	-	-	30,286	-	29,648	28,006	24,631	22,058	19,936	20,029	20,126	21,937	26,064	24,444	23,435	22,055	16,171	15,117	0	-	0	0	-	-	-	-	-	-	-	-	-
License, collaboration and other revenue
-	-	-	-	-	-	-	-	-	-	-	-	32,287	-	67,011	105,113	103,051	165,604	156,290	230,371	241,948	153,289	160,099	80,903	82,477	80,872	73,132	37,904	28,776	30,127	30,804	41,518	37,610	36,289	62,290	76,139	101,225	124,372	0	0	0
Operating costs and expenses:
Cost of goods sold
19,745	21,374	22,846	22,702	23,206	24,412	0	0	0	-	-	-	27,476	30,215	31,975	31,702	34,528	34,102	32,036	34,496	29,070	28,533	31,195	34,852	34,755	38,509	36,839	31,190	33,382	30,428	28,588	26,398	27,335	21,891	26,678	27,885	24,634	25,667	0	0	0
Research and development
425,090	434,566	433,080	436,927	418,575	399,536	372,082	334,901	306,827	268,461	237,264	223,501	215,591	203,801	200,704	191,982	185,044	182,787	174,146	165,117	156,407	147,734	157,488	167,202	182,730	190,010	188,135	178,237	159,208	148,675	135,604	132,606	131,675	126,766	124,919	121,625	114,955	108,065	0	0	0
General and administrative
99,923	98,712	95,347	90,082	87,762	81,443	70,003	63,340	59,075	52,364	52,786	50,984	46,023	44,275	44,751	44,042	43,191	43,266	42,279	41,865	41,300	40,925	38,511	40,024	39,631	40,532	41,562	40,987	42,029	41,614	42,248	44,530	45,447	46,760	46,847	44,678	43,700	40,986	0	0	0
Impairment of assets and other costs for terminated program
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,675	0	0	0	-	-	-	-	-	-	-	-
Total operating costs and expenses
589,947	554,652	551,273	549,711	529,543	505,391	484,770	441,817	412,945	367,353	317,448	303,242	289,090	278,291	277,430	267,726	262,763	260,155	248,461	241,478	226,777	217,192	227,194	242,078	257,116	269,051	266,536	250,414	234,619	222,392	208,115	205,209	206,132	195,417	211,020	206,764	195,865	187,294	0	0	0
Loss from operations
-452,979	-440,035	-430,692	-430,586	653,984	687,932	764,193	932,312	-91,944	-59,642	-67,753	-170,139	-157,808	-112,855	-110,074	-76,754	-81,898	-29,371	-37,495	42,407	62,960	-16,485	-14,893	-101,739	-111,428	-120,130	-127,615	-153,990	-148,373	-141,201	-132,288	-120,726	-128,002	-123,937	-110,008	-94,895	-58,764	-28,255	0	0	0
Non-operating income (expense):
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	2,526	2,545	2,444	2,244	1,903	1,650	1,514	1,545	0	0	0
Interest expense
22,288	21,310	21,297	21,314	21,468	21,582	21,800	21,898	22,023	22,085	22,002	22,076	22,193	22,468	22,709	21,297	19,788	18,282	16,948	17,137	17,507	17,869	17,977	18,173	18,341	18,453	18,570	19,680	17,586	15,489	13,332	10,178	10,186	10,223	10,186	10,469	10,808	11,174	0	0	0
Non-cash interest expense on liability related to sale of future royalties
25,900	25,000	24,280	23,281	22,281	21,200	20,173	19,830	19,367	18,900	18,318	18,749	19,219	19,712	20,120	20,444	20,614	20,619	20,592	20,569	20,551	20,888	21,389	21,802	22,153	22,309	22,060	21,931	21,815	18,057	0	0	0	-	-	-	-	-	-	-	-
Interest income and other income (expense), net
42,204	46,335	48,012	48,367	48,483	37,571	26,880	16,632	5,433	4,520	3,885	2,618	2,170	2,387	1,990	2,556	2,344	1,680	1,635	863	713	814	1,275	1,411	1,309	1,124	2,768	2,662	2,765	3,298	468	-405	-518	-1,044	-208	758	937	827	0	0	0
Total non-operating income (expense), net
-6,031	-19	2,474	3,811	4,773	-5,207	-15,062	-25,065	-35,926	-36,434	-36,435	-38,207	-39,242	-39,793	-54,918	-53,264	-52,137	-51,300	-35,905	-36,843	-37,345	-37,943	-38,730	-39,087	-39,499	-39,638	-39,088	-39,688	-36,954	-30,248	-22,979	-15,192	-10,045	-9,023	-8,491	-8,061	-8,357	-8,802	0	0	0
Loss before provision for income taxes
-459,010	-440,054	-428,218	-426,775	658,757	682,725	749,131	907,247	-127,870	-96,076	-104,188	-208,346	-197,050	-152,648	-164,992	-130,018	-134,035	-80,671	-73,400	5,564	25,615	-54,428	-53,623	-140,826	-150,927	-159,768	-166,703	-193,678	-185,327	-171,449	-155,267	-135,918	-138,047	-132,960	-118,499	-102,956	-67,121	-37,057	0	0	0
Provision for income taxes
676	613	-1,657	-2,879	1,284	1,412	3,432	4,534	748	616	877	814	842	876	470	423	460	506	-677	-521	-490	-512	2,269	2,214	2,224	2,245	577	606	494	406	1,157	1,027	994	1,018	564	750	721	881	0	0	0
Net loss
-459,686	-440,667	-426,561	-423,896	657,473	681,313	745,699	902,713	-128,618	-96,692	-105,065	-209,160	-197,892	-153,524	-165,462	-130,441	-134,495	-81,177	-72,723	6,085	26,105	-53,916	-55,892	-143,040	-153,151	-162,013	-167,280	-194,284	-185,821	-171,855	-156,424	-136,945	-139,041	-133,978	-119,063	-103,706	-67,842	-37,938	0	0	0
Basic and diluted net loss per share (in dollars per share)
-0.78	-	-	-	-0.69	-	-	-	-0.60	-	-	-	-0.42	-	-	-0.36	-0.14	-	-0.06	-0.40	-	-	-	-0.26	-	-	-	-0.37	-0.48	0.00	-0.38	-0.30	-0.36	0.00	-0.21	-0.32	-0.33	0.00	-0.09	-0.01	-0.07
Weighted average shares outstanding used in computing basic and diluted net loss per share (in shares)
177,185	-	-	-	173,859	-	-	-	160,884	-	-	-	153,666	-	-	136,350	135,793	-	132,631	131,643	-	-	-	127,040	-	-	-	115,544	115,309	115,185	114,915	114,649	114,531	114,525	114,413	114,153	108,677	94,407	94,213	94,065	93,631
Net income (loss) per share
Basic ( in dollars per share)
-	-	-0.56	-0.63	-	-	-0.56	5.67	-	-	0.39	-0.39	-	-	-0.32	-	-	-	-	-	0.26	-	0.55	-	-0.37	-	-0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in dollars per share)
-	-	-0.56	-0.63	-	-	-0.56	5.33	-	-	0.37	-0.39	-	-	-0.32	-	-	-	-	-	0.25	-	0.53	-	-0.37	-	-0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding used in computing net income (loss) per share
Basic (in shares)
-	-	175,402	174,549	-	-	172,698	171,378	-	-	156,411	155,352	-	-	137,094	-	-	-	-	-	131,359	-	127,504	-	123,543	-	115,812	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
-	-	175,402	174,549	-	-	172,698	182,291	-	-	162,641	155,352	-	-	137,094	-	-	-	-	-	135,667	-	132,177	-	123,543	-	115,812	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
Total revenue
19,163	20,117	18,662	17,360	18,877	20,774	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalty revenue
Total revenue
39,551	41,222	41,086	41,070	42,290	41,976	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash royalty revenue related to sale of future royalties
Total revenue
37,968	36,303	36,556	34,664	34,618	33,308	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License, collaboration and other revenue
Total revenue
40,286	16,975	24,277	26,031	1,087,742	1,097,265	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-